Coagulation studies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
*PT/INR | == Core Labs == | ||
* | === PT (Prothrombin Time) === | ||
* Measures extrinsic & common pathways (factors I, II, V, VII, X) | |||
* Normal: 11–13.5 sec | |||
* Prolonged in: warfarin use, liver disease, vitamin K deficiency, DIC | |||
=== INR (International Normalized Ratio) === | |||
* Standardized PT | |||
* Normal: 0.8–1.2 | |||
* Target therapeutic: 2–3 (DVT/PE/AF); 2.5–3.5 (mechanical valves) | |||
* >1.5 with bleeding or planned procedure may warrant reversal | |||
=== aPTT (Activated Partial Thromboplastin Time) === | |||
* Measures intrinsic & common pathways (factors I, II, V, VIII, IX, X, XI, XII) | |||
* Normal: 25–35 sec | |||
* Prolonged in: heparin, hemophilia A/B, lupus anticoagulant, DIC | |||
=== Fibrinogen === | |||
* Acute phase reactant; substrate for clot formation | |||
* Normal: 200–400 mg/dL | |||
* Low in: DIC, liver disease, fibrinolysis | |||
=== D-Dimer === | |||
* Marker of fibrin degradation | |||
* Normal: <500 ng/mL (varies by assay/age) | |||
* Elevated in: VTE, trauma, infection, cancer, pregnancy, DIC | |||
== Red Flags in the ED == | |||
* Bleeding with elevated PT/INR only: Think warfarin, liver disease, vitamin K deficiency. | |||
* Bleeding with elevated aPTT only: Think heparin, hemophilia, lupus anticoagulant. | |||
* Both PT and aPTT elevated: Consider DIC, liver failure, anticoagulant overdose. | |||
* Normal PT/aPTT with bleeding: Platelet dysfunction, von Willebrand disease, factor XIII deficiency. | |||
* Elevated D-dimer: Not specific — never diagnostic, but sensitive for VTE when combined with low Wells score. | |||
== Urgent Reversals == | |||
=== Warfarin (INR ≥3 or bleeding) === | |||
* Vitamin K IV + PCC (e.g., Kcentra) | |||
* FFP if PCC unavailable | |||
=== Heparin === | |||
* Protamine sulfate (1 mg per 100 units heparin given in last 2–3 hrs) | |||
=== DOACs (apixaban, rivaroxaban) === | |||
* Consider andexanet alfa (if available) | |||
* Activated charcoal if <2 hrs from ingestion | |||
* PCC off-label if bleeding and drug unknown | |||
{| class="wikitable" | |||
|+ Key Differentials by Lab Pattern | |||
|- | |||
! PT !! aPTT !! Diagnosis | |||
|- | |||
| ↑ || Normal || Warfarin, early liver disease | |||
|- | |||
| Normal || ↑ || Heparin, hemophilia, lupus inhibitor | |||
|- | |||
| ↑ || ↑ || DIC, advanced liver disease, vitamin K deficiency | |||
|- | |||
| Normal || Normal || Platelet disorder, von Willebrand disease | |||
|} | |||
== When to Order What == | |||
* PT/INR: On all bleeding patients, before procedures, warfarin monitoring | |||
* aPTT: If patient is on heparin or has unexplained bleeding | |||
* D-dimer: Rule out VTE in low-pretest probability | |||
* Fibrinogen/D-dimer: Suspect DIC, trauma, sepsis | |||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Revision as of 16:22, 5 May 2025
Core Labs
PT (Prothrombin Time)
- Measures extrinsic & common pathways (factors I, II, V, VII, X)
- Normal: 11–13.5 sec
- Prolonged in: warfarin use, liver disease, vitamin K deficiency, DIC
INR (International Normalized Ratio)
- Standardized PT
- Normal: 0.8–1.2
- Target therapeutic: 2–3 (DVT/PE/AF); 2.5–3.5 (mechanical valves)
- >1.5 with bleeding or planned procedure may warrant reversal
aPTT (Activated Partial Thromboplastin Time)
- Measures intrinsic & common pathways (factors I, II, V, VIII, IX, X, XI, XII)
- Normal: 25–35 sec
- Prolonged in: heparin, hemophilia A/B, lupus anticoagulant, DIC
Fibrinogen
- Acute phase reactant; substrate for clot formation
- Normal: 200–400 mg/dL
- Low in: DIC, liver disease, fibrinolysis
D-Dimer
- Marker of fibrin degradation
- Normal: <500 ng/mL (varies by assay/age)
- Elevated in: VTE, trauma, infection, cancer, pregnancy, DIC
Red Flags in the ED
- Bleeding with elevated PT/INR only: Think warfarin, liver disease, vitamin K deficiency.
- Bleeding with elevated aPTT only: Think heparin, hemophilia, lupus anticoagulant.
- Both PT and aPTT elevated: Consider DIC, liver failure, anticoagulant overdose.
- Normal PT/aPTT with bleeding: Platelet dysfunction, von Willebrand disease, factor XIII deficiency.
- Elevated D-dimer: Not specific — never diagnostic, but sensitive for VTE when combined with low Wells score.
Urgent Reversals
Warfarin (INR ≥3 or bleeding)
- Vitamin K IV + PCC (e.g., Kcentra)
- FFP if PCC unavailable
Heparin
- Protamine sulfate (1 mg per 100 units heparin given in last 2–3 hrs)
DOACs (apixaban, rivaroxaban)
- Consider andexanet alfa (if available)
- Activated charcoal if <2 hrs from ingestion
- PCC off-label if bleeding and drug unknown
| PT | aPTT | Diagnosis |
|---|---|---|
| ↑ | Normal | Warfarin, early liver disease |
| Normal | ↑ | Heparin, hemophilia, lupus inhibitor |
| ↑ | ↑ | DIC, advanced liver disease, vitamin K deficiency |
| Normal | Normal | Platelet disorder, von Willebrand disease |
When to Order What
- PT/INR: On all bleeding patients, before procedures, warfarin monitoring
- aPTT: If patient is on heparin or has unexplained bleeding
- D-dimer: Rule out VTE in low-pretest probability
- Fibrinogen/D-dimer: Suspect DIC, trauma, sepsis
